AKT1 and Ito hypomelanosis: Consistent with these results, our data confirmed that intracellular and extracellular S100A9 improved PA proliferation, migration and invasion through phosphorylation of AKT1, supporting S100A9 as a novel molecular target for the prediction and therapy of IPA.